These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27660611)

  • 1. From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine.
    Everett JR
    Front Pharmacol; 2016; 7():297. PubMed ID: 27660611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacometabonomics and personalized medicine.
    Everett JR; Loo RL; Pullen FS
    Ann Clin Biochem; 2013 Nov; 50(Pt 6):523-45. PubMed ID: 23888060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling.
    Everett JR
    Handb Exp Pharmacol; 2019; 260():263-299. PubMed ID: 31823071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacometabonomics in humans: a new tool for personalized medicine.
    Everett JR
    Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.
    Nicholson JK; Everett JR; Lindon JC
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):135-9. PubMed ID: 22248264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
    Everett JR
    Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
    Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
    Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacometabonomics - the novel way to personalized drug therapy].
    Maslov DL; Balashova EE; Lokhov PG; Archakov AI
    Biomed Khim; 2017 Mar; 63(2):115-123. PubMed ID: 28414282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review.
    Li B; He X; Jia W; Li H
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28703775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the personalized medicine using pharmacometabonomics].
    Huang Q; A JY; Zhou GH
    Yao Xue Xue Bao; 2014 Nov; 49(11):1491-7. PubMed ID: 25757272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years of metabonomics: so what has metabonomics done for toxicology?
    Griffin JL
    Xenobiotica; 2020 Jan; 50(1):110-114. PubMed ID: 31826699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacometabonomics: data processing and statistical analysis.
    Fu J; Zhang Y; Liu J; Lian X; Tang J; Zhu F
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33866355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacometabonomics, pharmacogenomics and personalized medicine.
    Guţiu IA; Andrieş A; Mircioiu C; Rădulescu F; Georgescu AM; Cioacă D
    Rom J Intern Med; 2010; 48(2):187-91. PubMed ID: 21428184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine.
    Beger RD; Schmidt MA; Kaddurah-Daouk R
    Metabolites; 2020 Mar; 10(4):. PubMed ID: 32230776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication.
    Jian J; He D; Gao S; Tao X; Dong X
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging technologies, recent developments, and novel applications for drug metabolite identification.
    Lu W; Xu Y; Zhao Y; Cen X
    Curr Drug Metab; 2014; 15(9):865-74. PubMed ID: 25537130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
    Mussap M; Loddo C; Fanni C; Fanos V
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
    [No Abstract]   [Full Text] [Related]  

  • 18. Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and Toxicity.
    Hu T; An Z; Sun Y; Wang X; Du P; Li P; Chi Y; Liu L
    Front Oncol; 2020; 10():548300. PubMed ID: 33282726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent development of metabonomics and its applications in clinical research].
    Li H; Jiang Y; He FC
    Yi Chuan; 2008 Apr; 30(4):389-99. PubMed ID: 18424407
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.